Skip to main content
Clinical Trials/CTRI/2018/03/012695
CTRI/2018/03/012695
Recruiting
N/A

Development and validation of indigenously developed mobile-Health diagnostic devices for real-time quantification of: Cardiac Troponin T, Lp-PLA2, Glucose, Insulin, HIV p24 antigen, Triiodothyronine, Thyroxine and Thyroid-Stimulating Hormone

Sri Sathya Sai Institute of Higher Learning0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- Patients with thyroid symptoms in fluoride endemic areas. Patients with acute coronary syndrome (ACS).
Sponsor
Sri Sathya Sai Institute of Higher Learning
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with known or suspected thyroid abnormalities and skeletal fluorosis.
  • For the patients with acute coronary syndrome, inclusion age is 18 and above, both males and females.

Exclusion Criteria

  • Patients below the age of 6 years and pregnant woman are excluded for thyroid study. Patients identified with Hashimoto thyroiditis will also be excluded from the thyroid study.
  • For heart study, patients with renal failure will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials